Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

The Go for Bold initiative, which aims to help individuals in Washington County, Maryland, lose 1 million lb by 2030, serves as a successful, replicable model for community-wide health improvement. In ...

Objectives To evaluate whether type 2 diabetes mellitus (T2DM) presence and severity are associated with differences in global and domain-specific cognitive function among US adults, using ...

Introduction Implementing shared decision-making (SDM) in maternity care remains challenging in low-income and middle-income ...

Objectives To estimate the rate of hospitalisation, identify associated factors and assess out-of-pocket expenditure (OOPE) among adults with multimorbidity in Kerala, India. Design Community-based ...

Data access empowerment operating models enable public health leaders to make timely, informed decisions with trusted intelligence and faster insights.

Alison Lumbatis shares strategies that helped transform her blog, Outfit Formulas, into a successful subscription business.

A new machine learning model built using a simple and interpretable approach predicts in-hospital death in patients with acute liver failure and reveals top risk drivers.

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...

This Research Topic focuses on using artificial intelligence (AI) to combine and analyze diverse biomedical data types to improve the performance and ...

According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...